Keryx Biopharmaceuticals Inc. Message Board

Regarding the appointment of Amit Sharma, M.D., the new Vice President, Medical Affairs, for Keryx, it was a major accomplishment to have Dr Sharma come on board. Strong move -

Amit Sharma, M.D., is an accomplished board certified nephrologist, internist, and hypertension specialist who has a broad-based background in chronic kidney disease and dialysis. Recently, Dr. Sharma was Medical Director, Medical Affairs, at Reata Pharmaceuticals. From 2005-2012, Dr. Sharma served as a Medical Director and Senior Advisor for Liberty Dialysis, LLC, a medium-size dialysis organization with over 300 dialysis clinics. Liberty was sold in 2011 to Fresenius Medical Care AG for $1.7 billion. From 2001 to 2005, Dr. Sharma served as the Director of the Dialysis Unit and of the Chronic Kidney Disease Clinic for the Naval Medical Center, San Diego.

Dr. Sharma received his medical degree from Louisiana State University Medical Center-New Orleans. He completed his fellowship in Nephrology and Hypertension from University of California in San Diego in 2001. Dr. Sharma also has extensive experience conducting primary research and as a principal investigator for numerous clinical trials in the field of nephrology and hypertension. He has published in many respected peer reviewed journals and he is a well known presenter for national and international meetings.

Ron Bentsur, the Company's Chief Executive Officer, commented, "We are thrilled to welcome Dr. Sharma to Keryx. Dr. Sharma has a prominent national reputation and a proven track record of success within the dialysis community. I believe that Dr. Sharma's vast knowledge and

Management wants in increase authorized share capital by 35,000,000. We may be in for a bumpy summer.

Tomorrow you will have to but back at the 8 dollar range

People have been comparing ACAD and KERX for a long time, I was long KERX made money now I am going to ACAD. They won and have the potential to make more money than we can. The FDA waived their secondary P3 trial, what you think they do that all the time? Name one other company the FDA told them, don't worry about doing a second confirmatory P3 Trial and then tell me that drug did not get approved. There are hundreds of biotech stocks, is there one out there? No there isn't. So hey it happens, they're winning and I want to get in now so I am not paying $30 a share a year from now. Good Luck!

inst are still accumulating shares couple more weeks of accumulation

test